Profile
Rachel Meyers is the founder of Faze Medicines, Inc. She is currently an Independent Director at Korro Bio, Inc. since 2023.
Previously, she worked as a Senior Scientist at Millennium Pharmaceuticals, Inc. from 1993 to 2003.
Additionally, she held the position of Vice President-Research & RNAi Lead Discovery at Alnylam Pharmaceuticals, Inc. from 2011 to 2013.
Dr. Meyers obtained a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from Brandeis University.
Rachel Meyers active positions
| Companies | Position | Start |
|---|
Former positions of Rachel Meyers
| Companies | Position | End |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2002-12-31 |
| Faze Medicines, Inc. | Founder | - |
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Rachel Meyers
| Massachusetts Institute of Technology | Doctorate Degree |
| Brandeis University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
| Faze Medicines, Inc. |
- Stock Market
- Insiders
- Rachel Meyers
